StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$10.88+0.01 (+0.05%)

Close on Nov 13, 2026Market cap $210.08MP/E –Yield –

Translational Development Acquisition EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

No eps figures for Translational Development Acquisition

Translational Development Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Translational Development Acquisition figures

See a number that looks wrong?